Rational combination immunotherapeutic approaches for effective cancer treatment

作者: Cao Dai Phung , Hanh Thuy Nguyen , Tuan Hiep Tran , Han-Gon Choi , Chul Soon Yong

DOI: 10.1016/J.JCONREL.2018.12.020

关键词:

摘要: … combination immunotherapy is the future of cancer treatment. However, designing safe and rational combinations of … optimal immunotherapy-based combinations mainly with respect to …

参考文章(196)
Steven A. Rosenberg, Gwendolyn Fyfe, Gwendolyn Fyfe, Richard I. Fisher, Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. The cancer journal from Scientific American. ,vol. 6, ,(2000)
A Mohamed Adil, V Lavanya, S Jamal, N Ahmed, None, Cancer immunotherapy: Targeting immunosuppressive tumor microenvironment Oncobiology and Targets. ,vol. 1, pp. 16- ,(2014) , 10.4103/2395-4469.145382
Jeffrey A. Sosman, Nicholas J. Vogelzang, Lynn J. Buchanan, Matthew L. Sherman, Michael B. Atkins, Janice P. Dutcher, John P. Leonard, John L. Ryan, Gerald L. Fisher, Glenn Larsen, Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production Blood. ,vol. 90, pp. 2541- 2548 ,(1997) , 10.1182/BLOOD.V90.7.2541
Ralf M. Leonhardt, Peniel M. Dimberu, Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear. Yale Journal of Biology and Medicine. ,vol. 84, pp. 371- 380 ,(2011)
Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce, J. Michael White, Paul E. Swanson, Lloyd J. Old, Robert D. Schreiber, IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature. ,vol. 410, pp. 1107- 1111 ,(2001) , 10.1038/35074122
Christopher R Heery, Nuhad K Ibrahim, Philip M Arlen, Mahsa Mohebtash, James L Murray, Kimberly Koenig, Ravi A Madan, Sheri McMahon, Jennifer L Marté, Seth M Steinberg, Renee N Donahue, Italia Grenga, Caroline Jochems, Benedetto Farsaci, Les R Folio, Jeffrey Schlom, James L Gulley, None, Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial JAMA Oncology. ,vol. 1, pp. 1087- 1095 ,(2015) , 10.1001/JAMAONCOL.2015.2736
Jonathan Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. OncoImmunology. ,vol. 4, ,(2015) , 10.1080/2162402X.2015.1008866